United States· US:82667-800_5386eec5-c123-04b8-e063-6294a90a2952
TRIESENCE
A triamcinolone product containing triamcinolone acetonide, registered in United States by Harrow Eye, LLC. The same ATC class is registered in 5 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Triamcinolone is registered in 5 of 19 countries.
Countries holding a registration under ATC S01BA05 (triamcinolone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Triamcinolone · ATC S01BA05
5 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRIAMCINOLONE ACETONIDE
- Manufacturer
- Harrow Eye, LLC
- Country
- United States (US)
- ATC code
- S01BA05
- ATC class
- Triamcinolone
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1182667-800-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
229 interactions on record for triamcinolone.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Triamcinolone · interactions on record
229 records
- 29 severe
- 199 moderate
- 1 minor
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Triamcinolone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTriesenceOrifarm Oy
- GermanyKortikoidRatiopharm Gmbh
- United KingdomAdcortyl in Orabase 0.1% oromucosal pasteBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsCremor triamcinolonacetonide 0,1% Mylan, creme 1 mg/gMylan B.V.
- NorwayKenacort RetardBristol-Myers Squibb
- BelgiumAlbicort 10Sanofi Belgium
- CanadaAPO-TRIAMCINOLONE AQAPOTEX INC
- Japanトリアムシノロンアセトニド
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Volon, Volon A
- Belgium · Delphi, Kenacort-A
- Cyprus · Triacort
- Czechia · Triamcinolon Léčiva
- Germany · Nasacort, Rhinisan
- Denmark · Kenalog, Triamcinolone Acetonide Medipha
- Estonia · Kenalog
- Spain · Nasacort
- Finland · Nasacort, Triamcinolone Medipha
- France · Kenacort Retard, Nasacort
- United Kingdom (Northern Ireland) · Nasacort
- Greece · Jiven, Nasacort
- Croatia · Kenalog
- Hungary · Ftorocort, Kenalog
- Ireland · Nasacort, Nasacort Allergy
- Iceland · Kenacort-T, Nasacort
- Italy · Kenacort, Nasacort
- Lithuania · Ftorocort, Kenalog
- Luxembourg · Delphi, Kenacort-A
- Latvia · Ftorocort, Kenalog
- Malta · Nasacort, Nasacort Allergy
- Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
- Norway · Kenacort-T, Nasacort
- Poland · Polcortolon
- Portugal · Nasacort, Telfast Spray Nasal
- Sweden · Kenacort-T, Nasacort
- Slovenia · Kenalog
- Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4157a947-d750-4b29-aee1-f3d7e8752e84 GET /v1/drugs/4157a947-d750-4b29-aee1-f3d7e8752e84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "40",
"substance": "TRIAMCINOLONE ACETONIDE",
"productndc": "82667-800",
"dosage_form": "INJECTION, SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA022048",
"marketing_category": "NDA"
}See everything about triamcinolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.